Rioprostil is a synthetic methylprostaglandin E1 analogue that reduces gastric acid secretion and enhances the gastric mucus-bicarbonate barrier. It is effective in the therapy of gastric ulcers and gives significant protection against NSAID-induced gastric mucosal damage. The drug also prevents cyclosporin A-induced damage to endocrine and exocrine pancreatic secretions. It shows a low order of acute toxicity and there is no evidence of embryotoxicity, fetotoxicity, teratogenicity, or mutagenicity in animal studies. References: Cohen A, Tolman KG, Lewis GP, Brown S, van Horn A, McCormack GH, Simon DM. The antigastrolesive activity of rioprostil, a 16-methyl prostaglandin-E1 analogue in healthy volunteers. Scand J Gastroenterol Suppl. 1989;164:81-90; discussion 90-1. PubMed PMID: 2510286.

纯度：≥98%

CAS：77287-05-9